We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates in two seg... Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates in two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity solutions. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions. Show more
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr...
Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600 PR Newswire NEW YORK, Jan. 7, 2025 NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Maplebear Inc. (NASD: CART) will replace...
Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet...
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9% on...
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.42 | 5.33745037494 | 45.34 | 48.29 | 45.34 | 541717 | 47.27618101 | CS |
4 | 3.75 | 8.52079072938 | 44.01 | 48.29 | 42.65 | 1378381 | 45.18619952 | CS |
12 | 6.18 | 14.8629148629 | 41.58 | 49.83 | 41.37 | 860877 | 45.6236615 | CS |
26 | 1.76 | 3.82608695652 | 46 | 49.83 | 38.27 | 737136 | 44.19807323 | CS |
52 | -12.38 | -20.5853009644 | 60.14 | 65.03 | 38.27 | 633073 | 47.93054407 | CS |
156 | -11.39 | -19.2561284869 | 59.15 | 72.13 | 38.27 | 526763 | 52.24888235 | CS |
260 | -11.39 | -19.2561284869 | 59.15 | 72.13 | 38.27 | 526763 | 52.24888235 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions